| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |